Toggle Main Menu Toggle Search

Open Access padlockePrints

Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial

Lookup NU author(s): Professor Gary Ford, Dr Isam Salih

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Background Extracranial carotid and vertebral artery dissection is an important cause of stroke, especially in young people. In some observational studies it has been associated with a high risk of recurrent stroke. Both antiplatelet drugs and anticoagulant drugs are used to reduce risk of stroke but whether one treatment strategy is more effective than the other is unknown. We compared their efficacy in the Cervical Artery Dissection in Stroke Study (CADISS), with the additional aim of establishing the true risk of recurrent stroke.Methods We did this randomised trial at hospitals with specialised stroke or neurology services (39 in the UK and seven in Australia). We included patients with extracranial carotid and vertebral dissection with onset of symptoms within the past 7 days. Patients were randomly assigned (1:1) by an automated telephone randomisation service to receive antiplatelet drugs or anticoagulant drugs (specific treatment decided by the local clinician) for 3 months. Patients and clinicians were not masked to allocation, but investigators assessing endpoints were. The primary endpoint was ipsilateral stroke or death in the intention-to-treat population. The trial was registered with EUDract (2006-002827-18) and ISRN (CTN44555237).Findings We enrolled 250 participants (118 carotid, 132 vertebral). Mean time to randomisation was 3.65 days (SD 1.91). The major presenting symptoms were stroke or transient ischaemic attack (n=224) and local symptoms (headache, neck pain, or Homer's syndrome; n=26). 126 participants were assigned to antiplatelet treatment versus 124 to anticoagulant treatment. Overall, four (2%) of 250 patients had stroke recurrence (all ipsilateral). Stroke or death occurred in three (2%) of 126 patients versus one (1%) of 124 (odds ratio [OR] 0.335, 95% CI 0.006-4.233; p=0.63). There were no deaths, but one major bleeding (subarachnoid haemorrhage) in the anticoagulant group. Central review of imaging failed to confirm dissection in 52 patients. Preplanned per-protocol analysis exduding these patients showed stroke or death in three (3%) of 101 patients in the antiplatelet group versus one (1%) of 96 patients in the anticoagulant group (OR 0.346,95% CI 0-006-4.390; p=0-66).Interpretation We found no difference in efficacy of antiplatelet and anticoagulant drugs at preventing stroke and death in patients with symptomatic carotid and vertebral artery dissection but stroke was rare in both groups, and much rarer than reported in some observational studies. Diagnosis of dissection was not confirmed after review in many cases, suggesting that radiographic criteria are not always correctly applied in routine clinical practice.Funding Stroke Association. Copyright (C)Markus et al. Open Access article distributed under the terms of CC BY.


Publication metadata

Author(s): Markus HS, Hayter E, Levi C, Feldman A, Venables G, Norris J, Peycke J, Willson M, Hicks C, Hayter E, Madigan J, Clifton A, Menon R, Kennedy F, Khan U, Feldman A, Hollocks M, Markus HS, King A, Madigan J, Markus HS, Norris J, Venables GS, Kerry S, Hassan A, Levi C, Ford GA, Bath PMW, Weir C, Kalra L, Briley D, Bhalla A, Reid J, Kumar R, Mawer S, Smith M, Ali K, Sharma P, Dutta D, Nor AM, Boswell R, Baldwin N, Rudd A, Stanley D, Burger I, Kalra L, Hassan A, Price C, Dixit A, MacWalter R, Cohen D, Davey R, Cassidy T, Gunathilagan G, Jenkinson D, Harrington F, James M, Venables G, Smyth N, Emsley H, Shaw L, Lovett J, Guyler P, Muir K, Markus HS, Gompertz P, Davies B, Kelly D, Salih I, Davies B, Shetty H, Mistri A, Hargroves D, Rashed K, Clarke B, Collas D, Gerraty R, Sturm J, Levi C, Kleinig T, Wong A, Hand P, Delcourt C, CADISS Trial Investigators

Publication type: Article

Publication status: Published

Journal: Lancet Neurology

Year: 2015

Volume: 14

Issue: 4

Pages: 361-367

Print publication date: 01/04/2015

Online publication date: 11/05/2014

Acceptance date: 01/01/1900

ISSN (print): 1474-4422

ISSN (electronic): 1474-4465

Publisher: Elsevier

URL: http://dx.doi.org/10.1016/S1474-4422(16)70018-9

DOI: 10.1016/S1474-4422(16)70018-9


Altmetrics

Altmetrics provided by Altmetric


Share